David Ray, DPM
Foot & Ankle Surgery · Schererville, INNPI 1932119989
Payments from drug & device makers
Across 57 payments — averaging $15.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sandoz$137
- GRT US Holding, Inc.$85
- Kerecis Limited$81
- Paratek Pharmaceuticals, Inc.$73
- Orthofix Medical, Inc.$72
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$54
- plus $403 from 13 others
What the payments were for
- Food & beverage$88297%
- Education$233%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sandoz | 13 | $137 |
| GRT US Holding, Inc. | 6 | $85 |
| Kerecis Limited | 5 | $81 |
| Paratek Pharmaceuticals, Inc. | 4 | $73 |
| Orthofix Medical, Inc. | 4 | $72 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $54 |
| Amgen | 4 | $53 |
| Osteomed LLC | 2 | $53 |
| Johnson & Johnson | 2 | $52 |
| Alfasigma USA, Inc. | 2 | $37 |
| IBSA Pharma Inc. | 2 | $31 |
| Assertio Therapeutics, Inc. | 1 | $25 |
| Treace Medical Concepts, Inc. | 1 | $25 |
| Merck | 2 | $25 |
| Organogenesis Inc. | 1 | $24 |
| Convatec Inc. | 1 | $23 |
| Vertex | 1 | $22 |
| Averitas Pharma Inc. | 1 | $17 |
| Novum Pharma, LLC | 1 | $16 |
How this compares
$904 in reported general payments places this provider in the 15th percentile of 212 foot & ankle surgery providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 531 | $6,288 |
| Pregabalin | 141 | $4,233 |
| Clotrimazole | 137 | $1,998 |
| Allopurinol | 148 | $1,278 |
| Methylprednisolone | 263 | $952 |
| Cephalexin | 158 | $762 |
| Ketoconazole | 25 | $589 |
| Ibuprofen | 120 | $514 |
| Terbinafine Hcl | 27 | $388 |
| Colchicine | 11 | $341 |
| Clindamycin Hcl | 53 | $203 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 31 | $96 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $74 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $71 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Schererville
- Robert Clemency IiiSchererville$215K
- Steven HerbstMuncie$1.6M
- Douglas BlacklidgeKokomo$689K
- Patrick DeheerIndianapolis$493K
- Scott NevilleMooresville$353K
- Travis MontgomeryWestfield$345K
- William AdamsGreenfield$178K
- Christopher WintersCarmel$158K
- Steven DouthettFort Wayne$153K
- Brian ElliottShelbyville$142K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.